NCT06244160 High Flow Oxygen Therapy After Spinal Cord Injury
| NCT ID | NCT06244160 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cardiff and Vale University Health Board |
| Condition | Spinal Cord Injuries |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2024-04-01 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2024-04-01 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this feasibility study is to learn about the ability to use a different form of oxygen therapy (known as high flow oxygen therapy) in patients who have a spinal cord injury in the upper back or neck. The main questions it aims to answer are: 1. Is it possible to recruit patients to the study 2. It is possible to follow the protocol in its current format 3. What is the impact on those receiving the intervention. Participants will be randomised to receive either standard care or high flow oxygen therapy for 10 days following inclusion.
Eligibility Criteria
Inclusion Criteria: 1. Spinal cord injury between C4 and T4 (Include ASIA A-D) 2. Admitted to spinal injury ward within 24-48hours of injury Exclusion Criteria: 1. Aged under 18 years 2. 3 or more rib fractures or flail 3. Sternal fracture 4. Concomitant lung injury 5. Unable to gain informed consent from participant 6. Contra-indication to using high flow therapy e.g., undrained pneumothorax, facial fractures, nasal obstruction, CSF leak, suspected or confirmed base of skull fracture, active epistaxis or recent functional endoscopic sinus surgery.
Contact & Investigator
Paul Twose
PRINCIPAL INVESTIGATOR
Cardiff and Vale University Health Board
Frequently Asked Questions
Who can join the NCT06244160 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Spinal Cord Injuries. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06244160 currently recruiting?
Yes, NCT06244160 is actively recruiting participants. Contact the research team at paul.twose@wales.nhs.uk for enrollment information.
Where is the NCT06244160 trial being conducted?
This trial is being conducted at Cardiff, United Kingdom.
Who is sponsoring the NCT06244160 clinical trial?
NCT06244160 is sponsored by Cardiff and Vale University Health Board. The principal investigator is Paul Twose at Cardiff and Vale University Health Board. The trial plans to enroll 30 participants.